| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.078 | 0.01 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |